about
Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girlsParadoxically high adiponectin and the healthy obese phenotype in obese black and white 16-year-old girls.Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years laterChildhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study.Risk factors for cardiovascular disease and type 2 diabetes retained from childhood to adulthood predict adult outcomes: the Princeton LRC Follow-up StudyDeterminants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health StudySevere vitamin d deficiency, myopathy, and rhabdomyolysisVKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot studyDoes low serum 25 OH vitamin D interact with very strenuous physical activity, facilitating development of rhabdomyolysis?Pediatric non-high-density lipoprotein cholesterol, the metabolic syndrome, and insulin resistanceHigh factor XI, recurrent pregnancy loss, enoxaparin.Determinants of persistent obesity and hyperinsulinemia in a biracial cohort: a 15-year prospective study of schoolgirls.Endothelial nitric oxide synthase T-786C mutation, a reversible etiology of Prinzmetal's angina pectoris.T-786C polymorphism of the endothelial nitric oxide synthase gene and neuralgia-inducing cavitational osteonecrosis of the jaws.Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.Race, childhood insulin, childhood caloric intake, and class 3 obesity at age 24: 14-year prospective study of schoolgirls.Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.Homeostasis model assessment of insulin resistance*body mass index interactions at ages 9 to 10 years predict metabolic syndrome risk factor aggregate score at ages 18 to 19 years: a 10-year prospective study of black and white girls.Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients.Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study.Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.Hyperinsulinemia and metabolic syndrome at mean age of 10 years in black and white schoolgirls and development of impaired fasting glucose and type 2 diabetes mellitus by mean age of 24 years.Stromelysin-1 5A/6A and eNOS T-786C polymorphisms, MTHFR C677T and A1298C mutations, and cigarette-cannabis smoking: a pilot, hypothesis-generating study of gene-environment pathophysiological associations with Buerger's disease.Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later.Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur.Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.Early and late menarche are associated with oligomenorrhea and predict metabolic syndrome 26 years later.Thromboembolismpeaking 3 months after starting testosterone therapy: testosterone-thrombophilia interactions.The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty.Thrombosis in three postmenopausal women receiving testosterone therapy for low libido.Adolescent and young adult female determinants of visceral adipose tissue at ages 26-28 years.Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years.Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
P50
Q33798608-5F3A381A-E5DB-492D-BBB7-66EFD16B0426Q34298807-2FB464C6-F67B-404C-8927-6A6299E552B9Q34496704-85C33E62-CA46-4B3D-A932-40B09776E7D7Q35884982-DA93BEB5-9FB8-42DD-99BD-EF836CB819FFQ36303204-A2070B26-8A29-4F5C-A832-672A7EE4D524Q37119772-1BFE5554-FC05-44E1-A72D-16FB1CE19284Q37201803-211AEAC6-A401-4B3F-B0B6-E11DC13D783BQ37213180-4867359E-4B7A-47CF-980B-C9F3FE816DDFQ38125023-3F5E5C5C-2FC4-4B80-97AA-0898963F818EQ42672019-A8989B7D-1411-4E57-99B6-DC363483E1C6Q42795650-3653243A-C706-4FF1-AC5E-D8B328C1E559Q43018027-8ADB288D-14C1-478A-9CA2-0B803D303A7BQ43138612-BF3AC8C9-897D-4481-872E-DAF7DD470952Q43149185-3A054E4C-AFDC-4DA9-9B46-CB777FE437E8Q43229974-51306ADF-96E2-4F8F-B3FA-D827197605DFQ44981325-B4ED1FA8-D6E7-469B-A8F6-A1E175355713Q46046386-A19F7E5E-AA17-4E3A-9C55-335E036BB1B9Q46122019-B4CA41C1-BBC0-467D-985B-29D889878694Q46125521-92F1272B-536C-42CF-B8B6-E7F6B0EDB41AQ46156355-3D393B1D-C736-4BB0-9598-67277913FF7EQ46187383-63E6EC6D-7137-4AF7-825B-F033102CFC4FQ46187390-C1928AE4-6FCE-477B-9E51-DD461ED76147Q46272830-0F6CCA73-D305-4301-82A4-D3C0CA2D40DCQ46363760-26C6C375-31A8-4633-949E-67D4100F48A9Q46538570-497CD243-6DCF-4FEE-A719-C95BA72649ECQ46771542-B2148E15-0422-4E06-B83F-A2728B6450FEQ46779466-99F82C16-EA95-4C26-A636-5579FBEF7BD7Q46799989-3644A4BC-5DF5-4AFF-B0F5-8CD69626DB8AQ46832277-FBD7BAE7-709F-4DCD-9045-150F142671EDQ46920912-43A1EE93-E933-4951-A614-18F5A644D402Q46948995-16A0A7E0-CC2D-4F0D-BA26-138446F0536EQ47311320-409967F9-689F-4291-9D9C-696671E65E70Q47311649-17C95F5D-8D63-46DE-B480-F12DB9A53AC9Q47760439-D94D4C58-59B0-4907-A1DC-A7A9EA57F6A7Q48105450-4CB300C8-6FB1-499D-AAA5-7AFC8E18E114Q48340094-76071208-2E7C-43C0-8C3B-09A3E0F15148Q50858322-2A822BBC-A2AF-41ED-8893-56A107BF59AAQ51060621-7661F818-0AD8-4B33-A8CE-519B15FAFA64Q51376610-810B409D-A2E0-47D7-A934-1FCAFE4EB06FQ51736818-FEF1D97C-99AA-439E-8800-A00B26E605A3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charles J Glueck
@ast
Charles J Glueck
@en
Charles J Glueck
@es
Charles J Glueck
@nl
Charles J Glueck
@sl
type
label
Charles J Glueck
@ast
Charles J Glueck
@en
Charles J Glueck
@es
Charles J Glueck
@nl
Charles J Glueck
@sl
prefLabel
Charles J Glueck
@ast
Charles J Glueck
@en
Charles J Glueck
@es
Charles J Glueck
@nl
Charles J Glueck
@sl
P106
P21
P31
P496
0000-0002-7932-9866